A phase 1 first in human open labe dose escalation study of MGD007 a humanized gpA33 x CD3 dual affinity retargeted (DART) protein i patients with relapsed refractory metastatic colorectal carcinoma
Clinical Trial Grant
Awarded By
MacroGenics, Inc.
Start Date
November 1, 2014
End Date
September 27, 2019
Awarded By
MacroGenics, Inc.
Start Date
November 1, 2014
End Date
September 27, 2019